Gemcitabine Combination Nano Therapies for Pancreatic Cancer

• Main Authors: Kamalika Samanta (Author), Saini Setua (Author), Sonam Kumari (Author), Meena Jaggi (Author), Murali M. Yallapu (Author), Subhash C. Chauhan (Author)
• Format: Book
• Published: MDPI AG, 2019-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pancreatic cancer is one of the deadliest causes of cancer-related death in the United States, with a 5-year overall survival rate of 6 to 8%. These statistics suggest that immediate medical attention is needed. Gemcitabine (GEM) is the gold standard first-line single chemotherapy agent for pancreat...